K.C. Pharmaceuticals, Inc FDA Record
- Latest inspection OAI · Feb 13, 2026
- Last warning letter 2026
K.C. Pharmaceuticals, Inc has 23 FDA recalls, 11 inspections, 0 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to K.C. Pharmaceuticals, Inc, the most recent on Aug 12, 2026.
- Latest recall
- D-0006-2027 · Class II · Sep 11, 2026
- Latest inspection
- Feb 13, 2026 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 23 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 11 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 3 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
K.C. Pharmaceuticals, Inc: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 1 | 1 | 16 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 1 | 1 | 1 | 2 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing K.C. Pharmaceuticals, Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check K.C. Pharmaceuticals, Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
K.C. Pharmaceuticals, Inc FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Aug 12, 2026 · Letter on fda.gov | CGMP/Finished Pharmaceuticals/Adulterated | Center for Drug Evaluation and Research (CDER) | |
| Aug 3, 2023 · Letter on fda.gov | CGMP/Finished Pharmaceuticals/Adulterated | Division of Pharmaceutical Quality Operations IV | |
| May 21, 2010 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0006-2027 | Class II | Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL… | Sep 11, 2026 |
| D-0004-2027 | Class II | Sterile EYE DROPS Advanced Relief, (dextran 70, 0.1%, polyethylene glycol 400 1% and… | Sep 11, 2026 |
| D-0008-2027 | Class II | Sterile Eye Drops Redness Relief (Glycerin 0.25%, Naphazoline HCl 0.02% Lubricant | Redness… | Sep 11, 2026 |
| D-0009-2027 | Class II | Sterile High Performance Ultra Lubricating Eye Drops (Polyethylene Glycol 400, 0.4% Relieves Dry… | Sep 11, 2026 |
| D-0002-2027 | Class II | Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15… | Sep 11, 2026 |
| D-0003-2027 | Class II | Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl. oz. (15 mL) bottles… | Sep 11, 2026 |
| D-0007-2027 | Class II | Sterile Eye Drops, ORIGINAL, Tetrahydrozoline HCl 0.05% Redness Reliever ¿ Fast Acting Formula)… | Sep 11, 2026 |
| D-0005-2027 | Class II | Eye Drops MAXIMUM, REDNESS RELIEF, Sterile, 1/2 FL OZ (0.5 ML); a) exchange select, Manufactured for… | Sep 11, 2026 |
| D-0412-2026 | Class II | Ultra Lubricating Eye Drops (polyethylene 400 0.4%, propylene glycol 0.3%), Sterile, 0.5 FL OZ… | Mar 3, 2026 |
| D-0415-2026 | Class II | STERILE EYE DROPS SOOTHING TEARS (polyethylene glycol 400 0.4% and propylene glycol 0.3%), 0.5 OZ… | Mar 3, 2026 |
| D-0413-2026 | Class II | Sterile Eye Drops ORIGINAL FORMULA (tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15mL) bottles; a) Good… | Mar 3, 2026 |
| D-0410-2026 | Class II | EYE DROPS Advanced Relief, (dextran 70 0.1%, polyethylene glycol 400 1% and tetrahydrozoline HCl… | Mar 3, 2026 |
| D-0411-2026 | Class II | Dry Eye Relief Eye Drops, (glycerin 0.2%, hypromellose 0.2% and polyethylene glycol 400 1%) 0.5 FL… | Mar 3, 2026 |
| D-0409-2026 | Class II | Sterile EYE DROPS AC (tetrahydrozoline HCl 0.05%, zinc sulfate 0.25%), 0.5 fl. oz. (15 mL) bottles… | Mar 3, 2026 |
| D-0416-2026 | Class II | Artificial Tears Sterile Lubricant Eye Drops (polyvinyl alcohol 0.5%, povidone 0.6%), 0.5 FL OZ (15… | Mar 3, 2026 |
| D-0414-2026 | Class II | Sterile EYE DROPS REDNESS LUBRICANT (glycerin 0.25% and naphazoline HCl 0.012%), 0.5 fl oz (15 mL)… | Mar 3, 2026 |
| D-0898-2023 | Class II | Dry Eye Relief Lubricant Eye Drops, (Glycerin 0.2%, Hypromellose 0.2 %, Polyethylene glycol 400 1%)… | Jun 13, 2023 |
| D-0897-2023 | Class II | Original Eye Drops; Redness Reliever; (Tetrahydrozoline HCl), 0.05%, 0.5 FL OZ (15mL); distributed… | Jun 13, 2023 |
| D-0322-2015 | Class III | Eye Drops Industrial Strength (Polyethylene glycol 400 1%, Tetrahydrozoline HCl 0.05%), 0.5 FL OZ… | Dec 4, 2014 |
| D-0320-2015 | Class III | Eye Drops (Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the Counter. Labeled: a)… | Dec 4, 2014 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 13, 2026 | Pomona, CA | Drugs | Official Action Indicated (OAI) | 2026940 |
| Aug 28, 2024 | Pomona, CA | Drugs | Voluntary Action Indicated (VAI) | 2026940 |
| Feb 13, 2023 | Pomona, CA | Drugs | Official Action Indicated (OAI) | 2026940 |
| Jan 30, 2020 | Pomona, CA | Drugs | Voluntary Action Indicated (VAI) | 2026940 |
| Nov 16, 2017 | Pomona, CA | Drugs | Voluntary Action Indicated (VAI) | 2026940 |
| Mar 19, 2015 | Pomona, CA | Drugs | Voluntary Action Indicated (VAI) | 2026940 |
| May 23, 2014 | Pomona, CA | Devices | No Action Indicated (NAI) | 2026940 |
| Jun 10, 2013 | Pomona, CA | Drugs | Official Action Indicated (OAI) | 2026940 |
| Aug 1, 2012 | Pomona, CA | Devices | Voluntary Action Indicated (VAI) | 2026940 |
| Feb 14, 2011 | Pomona, CA | Devices | Voluntary Action Indicated (VAI) | 2026940 |
| Dec 30, 2009 | Pomona, CA | Devices | Official Action Indicated (OAI) | 2026940 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 3 compliance actions under K.C. Pharmaceuticals, Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 2026940 | Pomona, CA | 11 | Feb 13, 2026 |
K.C. Pharmaceuticals, Inc and the FDA: common questions
Has K.C. Pharmaceuticals, Inc received an FDA warning letter?
Yes. FDA has issued 3 warning letters to K.C. Pharmaceuticals, Inc. The most recent is dated Aug 12, 2026, with the subject "CGMP/Finished Pharmaceuticals/Adulterated".
Has K.C. Pharmaceuticals, Inc received an FDA Form 483?
FDA has not published a Form 483 for "K.C. Pharmaceuticals, Inc" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect K.C. Pharmaceuticals, Inc?
The most recent FDA inspection on file ended Feb 13, 2026 at Pomona, CA and was classified OAI. FDA has 11 inspections of K.C. Pharmaceuticals, Inc on file, 4 of them classified OAI (official action indicated).
Has K.C. Pharmaceuticals, Inc had an FDA recall?
Yes. K.C. Pharmaceuticals, Inc has 23 FDA recalls on record. The most recent started Sep 11, 2026.
Need more than this page shows? Ask about K.C. Pharmaceuticals, Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.